Amgen (AMGN) SEC Filings & 10K Form

$307.31
+7.01 (+2.33%)
(As of 05/8/2024 ET)

Recent Amgen SEC Filings

DateFilerForm TypeView
05/08/2024
6:56 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:57 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:58 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:30 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:31 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:32 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:33 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:34 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:35 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:36 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:36 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:37 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
7:39 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
7:23 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
7:24 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
7:25 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:48 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:17 PM
Amgen (Subject)
Grygiel Nancy A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
6:18 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:19 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:20 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:22 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:23 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:24 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:25 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
6:59 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
7:00 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
7:01 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
7:44 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:50 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:50 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:51 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:53 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:54 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
6:55 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:04 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:05 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:07 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:09 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:10 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:11 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Elon Musk Secret Crypto Plot Exposed (Ad)

Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.

Click here now to get your copy.
03/20/2024
7:12 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
6:58 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
6:59 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
7:00 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:34 PM
Amgen (Issuer)
Santos Esteban (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:24 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:25 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:26 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:27 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:29 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:30 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:31 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:32 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:23 PM
Amgen (Issuer)
Bradway Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:23 PM
Amgen (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2024
6:50 PM
Amgen (Issuer)
Bradner James E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
10:35 AM
Amgen (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
12/19/2023
7:38 PM
Amgen (Issuer)
Bradner James E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/14/2023
8:16 AM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
6:40 PM
Amgen (Subject)
Grygiel Nancy A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
6:41 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
7:44 PM
Amgen (Issuer)
REESE DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
7:30 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
1:11 PM
Amgen (Subject)
Graham Jonathan P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2023
7:06 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
7:09 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
7:10 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
7:12 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
7:15 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
7:16 PM
Amgen (Issuer)
Khosla Rachna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
7:20 PM
Amgen (Issuer)
Miller Derek (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
6:43 PM
Amgen (Issuer)
Graham Jonathan P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
6:44 PM
Amgen (Issuer)
Griffith Peter H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
6:15 AM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
3:35 PM
Amgen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/05/2023
6:43 AM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
6:30 AM
Amgen (Filed by)
Neumora Therapeutics, Inc. (Subject)
Form SC 13D
09/19/2023
6:52 PM
Amgen (Reporting)
Neumora Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
5:58 PM
Amgen (Reporting)
Neumora Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2023
6:30 AM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2023
8:12 AM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2023
8:25 AM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2023
6:36 PM
Amgen (Issuer)
Busch Matthew C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/11/2023
5:13 PM
Amgen (Issuer)
Gordon Murdo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
7:55 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
7:56 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
7:57 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
2:18 PM
Amgen (Subject)
Gordon Murdo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2023
3:12 PM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2023
7:45 PM
Amgen (Issuer)
Grygiel Nancy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The 2024 Gold Rush: Unleashing Market Potential (Ad)

Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.

Get your free information kit NOW, before it's too late.
06/14/2023
6:31 PM
Amgen (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/05/2023
7:00 AM
Amgen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2023
6:17 PM
Amgen (Issuer)
Austin Wanda M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
6:18 PM
Amgen (Issuer)
Drake Michael V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
6:19 PM
Amgen (Issuer)
Druker Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
6:20 PM
Amgen (Issuer)
ECKERT ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
6:21 PM
Amgen (Issuer)
Garland Greg C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
6:22 PM
Amgen (Issuer)
HOLLEY CHARLES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
6:24 PM
Amgen (Issuer)
ISHRAK OMAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AMGN) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners